Coegin Pharma AB (NGM:COEGIN)
Sweden
· Delayed Price · Currency is SEK 3.710
-0.040 (-1.07%)
At close: Mar 6, 2026
Coegin Pharma AB Market Cap
Coegin Pharma AB has a market cap or net worth of 92.30 million as of March 9, 2026. Its market cap has increased by 6.03% in one year.
Market Cap
92.30M
Enterprise Value
84.37M
Revenue
79.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.71
Market Cap Chart
Since May 7, 2021, Coegin Pharma AB's market cap has decreased from 148.38M to 92.30M, a decrease of -37.80%. That is a compound annual growth rate of -9.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 92.30M | -16.44% |
| Dec 30, 2025 | 110.46M | 40.73% |
| Dec 30, 2024 | 78.49M | 55.23% |
| Dec 29, 2023 | 50.56M | -47.61% |
| Dec 30, 2022 | 96.51M | -57.65% |
| Dec 30, 2021 | 227.88M | 53.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Railway Metrics and Dynamics Sweden AB | 89.55M |
| Spotlight Group AB | 99.41M |
| Mediacle Group AB | 78.19M |
| ODI Pharma AB | 75.52M |
| Ramlösa shipping AB | 73.31M |
| Amido AB | 117.55M |
| Eurobattery Minerals AB | 121.93M |
| Abera Bioscience AB | 125.04M |